We are pleased to announce that the clinical trial for the AIM cat medicine has officially started at 26 veterinary hospitals across Japan. We are deeply grateful for your continued support.
We are fully committed to ensuring the trial progresses smoothly and to obtaining approval as soon as possible. We kindly ask for your continued support and encouragement as we move forward.